The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Therapeutic Pathways for Antimicrobial Use: Pediatric Issues
Author(s)James McCarty, MD, Lorna Dyk, RN, MBA
Advertisement
Articles in this issue
about 28 years ago
Optimizing Antimicrobial Therapy and Emerging Pathogensabout 28 years ago
Participating Facultyabout 28 years ago
Introductionabout 28 years ago
Mechanisms and Current Rates of Resistanceabout 28 years ago
Influence of Antibiotics on the Normal Floraabout 28 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 28 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysabout 28 years ago
CME QuizAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
2
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
5